HomeCompareRNUGF vs NNN

RNUGF vs NNN: Dividend Comparison 2026

RNUGF yields 181818.18% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RNUGF wins by $1.8951031795759825e+29M in total portfolio value
10 years
RNUGF
RNUGF
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full RNUGF calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — RNUGF vs NNN

📍 RNUGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRNUGFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RNUGF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RNUGF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RNUGF
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, RNUGF beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RNUGF + NNN for your $10,000?

RNUGF: 50%NNN: 50%
100% NNN50/50100% RNUGF
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

RNUGF
No analyst data
Altman Z
-38.7
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RNUGF buys
0
NNN buys
0
No recent congressional trades found for RNUGF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRNUGFNNN
Forward yield181818.18%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$1.8951031795759825e+29M$25.6K
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00$2,637.42
Total dividends collected$1.8949690612486723e+29M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RNUGF vs NNN ($10,000, DRIP)

YearRNUGF PortfolioRNUGF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$18,192,518$18,181,818.18$10,737$617.02+$18.18MRNUGF
2$30,932,835,887$30,913,369,892.64$11,577$710.93+$30932.82MRNUGF
3$49,156,619,660,049$49,123,521,525,649.34$12,538$822.59+$49156619.65MRNUGF
4$73,009,768,971,452,110$72,957,171,388,415,860.00$13,645$956.06+$73009768971.44MRNUGF
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$14,925$1,116.51+$101348671691011.75MRNUGF
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$16,415$1,310.57+$131490628941834960.00MRNUGF
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$18,158$1,546.77+$159445709700484431872.00MRNUGF
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$20,213$1,836.20+$1.8070656065589233e+23MRNUGF
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$22,649$2,193.37+$1.9141674430419936e+26MRNUGF
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$25,558$2,637.42+$1.8951031795759825e+29MRNUGF

RNUGF vs NNN: Complete Analysis 2026

RNUGFStock

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

Full RNUGF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this RNUGF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RNUGF vs SCHDRNUGF vs JEPIRNUGF vs ORNUGF vs KORNUGF vs MAINRNUGF vs ADCRNUGF vs EPRTRNUGF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.